Both in Surgical Instruments
Cerus vs MiMedx Group
Over the past year CERS returned +55.3% and MDXG returned −56.4%; their daily moves had a correlation of 0.25.
CERS +55.3% MDXG −56.4%Growth of $1, one year, split-adjusted
| Metric | CERS | MDXG |
|---|---|---|
| Price | $2.36 | $3.28 |
| Market cap | $475.6M | $478.6M |
| Today | +3.51% | −15.46% |
| 1 month | +3.5% | −28.5% |
| 6 months | −13.2% | −9.1% |
| Year to date | +14.6% | −51.6% |
| 1 year | +68.6% | −55.7% |
| Revenue growth (YoY) | +5.3% | −45.2% |
| Gross margin | 55.9% | 79.8% |
| Net margin | −4.6% | −13.9% |
| P/E (TTM) | — | — |
| Price / sales | 1.9× | 1.6× |
| Net cash | -$8.7M | $120.8M |
| Dividend yield | — | — |
| Volatility (60d) | 46.6% | 51.8% |
| Short % of float | 8.6% | 8.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).